Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104039 · ClinicalTrials.gov registry record
Brain Changes in Children and Adolescents With Behavioral Problems
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 318
- Enrollment target
NCT00104039: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00104039 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 318 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00104039 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 318 participants
- Enrollment target
Study Summary
Purpose: This study will examine brain activity in children age 10-18 with disruptive behavior problems, including conduct disorder (CD), oppositional defiant disorder (ODD), and attention deficit hyperactivity disorder (ADHD), compared with children without behavioral problems. Our goal is to examine differences in how emotions, social situations, and problem-solving situations are processed in the brain across these groups of children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2005-02-17 |
| Est. Completion | 2016-07-21 |
What the finished NCT00104039 record still lists
NCT00104039 is an observational study that tracks outcomes without assigning an intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00104039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00104039 about?
NCT00104039 is a clinical study titled "Brain Changes in Children and Adolescents With Behavioral Problems". Purpose: This study will examine brain activity in children age 10-18 with disruptive behavior problems, including conduct disorder (CD), oppositional defiant disorder (ODD), and attention deficit hyperactivity disorder (ADHD), compared with children without behavioral problems. Our goal is to exam...
What is the current status of trial NCT00104039?
This trial is currently completed. The enrollment target is 318 participants. The study started on 2005-02-17. Estimated completion is 2016-07-21.
Who is sponsoring clinical trial NCT00104039?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI